Table 2 |
|||
|
Univariate comparison of clinical variables among patients with good prognosis and poor prognosis |
|||
| Alive (n = 121) |
Deceased (n = 38) |
P value |
|
|
|
|||
| Proportion of patients with poor prognosis score (%) |
0.34 |
0.74 |
<0.0001 |
| Mean age at breast cancer diagnosis (years) |
57.5 (±12.4) |
58.8 (±16.8) |
0.59 |
| Mean tumor size (mm) |
21.3 (±11.5) |
25.6 (±12.6) |
0.05 |
| Proportion of patients with tumor size <21 mm (%) |
0.65 |
0.47 |
0.06 |
| Proportion of patients with positive lymph nodes (%) |
0.37 |
0.39 |
0.71 |
| Proportion of patients with grade I (%) |
0.23 |
0.08 |
0.06a |
| Proportion of patients with grade II (%) |
0.41 |
0.36 |
|
| Proportion of patients with grade III (%) |
0.36 |
0.56 |
|
| Proportion of patients with estrogen-receptor-positive tumors (%) |
0.83 |
0.79 |
0.61 |
| Proportion of patients with progesterone-receptor-positive tumors (%) |
0.77 |
0.55 |
0.01 |
| Proportion of patients receiving chemotherapy (%) |
0.18 |
0.21 |
0.69 |
| Proportion of patients receiving endocrine therapy (%) |
0.76 |
0.58 |
0.03 |
| Proportion of patients receiving radiotherapy (%) |
0.51 |
0.39 |
0.21 |
|
|
|||
|
Continuous variables compared using t tests; proportions compared using chi-squared tests. aCombined testing using the chi-squared test. |
|||
|
Pawitan et al. Breast Cancer Research 2005 7:R953 doi:10.1186/bcr1325 |
|||
